As a small, highly-leveraged company that must compete with brand-name goliaths such as Clorox (NYSE:CLX), Procter & Gamble (NYSE:PG) and Unilever (NYSE:UL) on a daily basis, it's not altogether surprising that Helen Of Troy (Nasdaq:HELE) shares can be very volatile. Today's poor growth numbers are certainly a concern, as are the company's long-term market position and cash flow leverage, but aggressive investors may see opportunity emerging in a company that has often been knocked down, only to rise once again.

Investopedia Broker Guide: Enhance your trading with the tools from today's top online brokers.

A Disappointing Fiscal Second Quarter
Helen of Troy's fiscal first quarter was also disappointing, and at the time I mentioned that I thought management's guidance for the year seemed optimistic. Apparently that is so, as sales look weak, and management has lowered full-year profit expectations.

Reported sales rose less than 4% this quarter, not only missing the average analyst estimate by 4%, but also showing marked deceleration from the double-digit growth of the fiscal first quarter. Revenue rose a reported 1% in housewares and more than 12% in healthcare/home environment, but fell more than 2% in personal care.

In point of fact, however, performance was worse. Stripping out the revenue tied to PUR (which the company bought from Procter & Gamble last year), organic revenue actually declined 6% overall (with a sharp 14% drop in the healthcare/home environment category).

Margin leverage also continues to be elusive. Gross margin did finally improve, growing about 20 basis points from last year and 30 basis points from the previous quarter. Operating income was up less than 2%, however, and the operating margin slipped slightly.

SEE: Find Investment Quality In The Income Statement

Transitory Problems ... Or Deeper Issues?
Three months ago, I speculated that the company was seeing (or about to see) greater pressure from increased promotional activities at major rivals such as Procter & Gamble, Unilever and Clorox. And now management has acknowledged some of that impact, at least in the personal care division.

While Helen of Troy does enjoy good placement at major retailers like Walmart (NYSE:WMT) and Target (NYSE:TGT), it's hard to gain share against the market leaders like P&G, Unilever, Conair and Colgate-Palmolive (NYSE:CL), when they're willing to sacrifice revenue/gross margin to hold share. So even though Helen of Troy's relatively higher weighting toward value pricing ought to help, that competitive promotional activity makes life harder.

I have some longer-term worries about Helen of Troy as well. By and large, nobody sees much growth potential in the North American personal care market anymore; companies like P&G and Unilever are increasingly having to tout their emerging market exposure to maintain investor enthusiasm. That makes me wonder about the extent to which these large companies will continue to use promotional to maintain share and cash flow, while using overseas markets to drive growth.

SEE: Industry Handbook: Porter's 5 Forces Analysis

The Bottom Line
I don't believe Helen of Troy is finished building its business; as Spectrum Brands (NYSE:SPB) showed recently in its deal with Stanley Black & Decker (NYSE:SWK), there's almost always someone looking to sell consumer brands at a reasonable price. What I do worry about, though, is whether the company can deliver the margin and cash flow leverage that is so critical to the stock working on a long-term basis.

If Helen of Troy can continue to post mid-single digit growth and boost the free cash flow margin into the double digits by 2022, this stock ought to be worth something close to $40. If the free cash flow margin only moves into the high single-digits, the target drops to the low $30s. This stock has rewarded prudent aggressiveness in the past, and I think it will do so again - this is certainly a rough spot in the company's history, but I do believe 2013 could be a better year for the company and this stock is worth a spot on the watch list of more aggressive investors.

At the time of writing, Stephen D. Simpson did not own any shares in the companies mentioned.

Related Articles
  1. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  2. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  3. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  4. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  5. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  6. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  7. Professionals

    What to do During a Market Correction

    The market has what? Here's what you should consider rather than panicking.
  8. Mutual Funds & ETFs

    ETF Analysis: Vanguard Mid-Cap Value

    Take an in-depth look at the Vanguard Mid-Cap Value ETF, one of the largest and most popular mid-cap funds in the U.S. equity space.
  9. Mutual Funds & ETFs

    ETF Analysis: Schwab US Broad Market

    Take an in-depth look at the Schwab U.S. Broad Market ETF, an incredibly low-cost fund based on a wide selection of the U.S. equity market.
  10. Professionals

    Tips for Helping Clients Though Market Corrections

    When the stock market sees a steep drop, clients are bound to get anxious. Here are some tips for talking them off the ledge.
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  3. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  4. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
  5. Ltd. (Limited)

    An abbreviation of "limited," Ltd. is a suffix that ...
  6. BHD (Berhad)

    The suffix Bhd. is an abbreviation of a Malay word "berhad," ...
  1. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  2. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  3. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  4. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  5. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
  6. What happens to the shares of stock purchased in a tender offer?

    The shares of stock purchased in a tender offer become the property of the purchaser. From that point forward, the purchaser, ... Read Full Answer >>

You May Also Like

Trading Center

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!